ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000027 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
5,959
Total Value
$607,448.29
P&L
+inf% (+$1,248,680.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Common Stock | โ | Feb 12, 2026 | Grant/Award | 4,000 | $0.00 | $0.00 | 33,728 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Feb 13, 2026 | Sale | 1,959 | $310.08 | $607,448.29 | 31,769 | Direct | โ | View Details |